What type of study is this?

This is a Animal Study study (also classified as: In Vitro Study).

What question did this study set out to answer?

This research aims to evaluate the effects of minimal PEGylation on the pharmacokinetic performance and immune compatibility of a lytic bacteriophage against MDR Acinetobacter baumannii.

December 10, 2025ACS Infectious Diseases

Minimal PEGylation Improves Pharmacokinetics, Immunocompatibility, and Efficacy of a Lytic Bacteriophage against Multidrug-Resistant Acinetobacter baumannii

View Full Paper

Ask AI

Bookmark

Authors

YCYoon-Jung ChoiINSEAD SKShukho KimINSEAD JJJi Yun JeongKyungpook National University

Discussion

Member takes

Implication

Preclinical evaluation shows minimal PEGylation improves pharmacokinetics and cytokine responses in Acinetobacter-infected mice, suggesting better infection management.

Key Points

This research aims to evaluate the effects of minimal PEGylation on the pharmacokinetic performance and immune compatibility of a lytic bacteriophage against MDR Acinetobacter baumannii.
Conjugated phage vB_AbaSt_W16 with methoxy polyethylene glycol succinimidyl ester (mPEG-S-NHS) at low concentration (4.2 pM).
Characterized PEGylation efficiency, infectivity, and stability both in vitro and in vivo.
Assessed pharmacokinetics in BALB/c mice after intraperitoneal challenge with MDR A. baumannii.
Profiled immune responses through cytokine quantification and ELISA for antiphage IgG.
Minimal PEGylation notably increased half-life by 2.7-3.7 times and reduced systemic clearance by over 200-fold.
Achieved complete bacterial clearance within 72-96 hours post-administration.
Showed reduced proinflammatory cytokine responses and lower antiphage IgG titers, indicating improved immune compatibility.

Cite This Study

Choi et al. (2025) studied this question.

synapsesocial.com/papers/69401b372d562116f28f7d9f https://doi.org/10.1021/acsinfecdis.5c00755

View Full Paper

Ask AI

Bookmark

Implication

Preclinical evaluation shows minimal PEGylation improves pharmacokinetics and cytokine responses in Acinetobacter-infected mice, suggesting better infection management.

Minimal PEGylation Improves Pharmacokinetics, Immunocompatibility, and Efficacy of a Lytic Bacteriophage against Multidrug-Resistant Acinetobacter baumannii

Discussion

Member takes

Implication

Key Points

Cite This Study

Minimal PEGylation Improves Pharmacokinetics, Immunocompatibility, and Efficacy of a Lytic Bacteriophage against Multidrug-Resistant Acinetobacter baumannii

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider